Suppression of Colorectal Cancer Liver Metastasis and Extension of Survival by Expression of Apolipoprotein(a) Kringles
Open Access
- 1 October 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (19) , 7092-7098
Abstract
The formation of hepatic metastases in colorectal cancer is the main cause of patient death. Current therapies directed at hepatic metastasis of colorectal cancer have had minimal impact on outcome. Therefore, alternative treatment strategies for liver metastasis require development. The present study was performed to evaluate the application of cDNA of LK68 encoding apolipoprotein(a) kringles IV-9, IV-10, and V as possible candidates for gene therapy treatment of this life-threatening disease. The murine colorectal cancer cell line CT26 was transduced ex vivo with LK68 cDNA via retroviral gene transfer, and an experimental model of hepatic metastasis was established by injecting LK68-expressing and control cells into the spleens of BALB/c mice. Expression of LK68 did not affect the growth characteristics and viability of transduced CT26 cells in vitro. LK68 produced from CT26 cells substantially inhibited the migration of endothelial cells in vitro. In vivo, substantial suppression of liver metastasis and prolonged survival were observed in mice bearing LK68-expressing CT26 cells, compared with controls. LK68-expressing liver metastases were restricted to smaller sizes and displayed decreased microvessel density and increased tumor cell apoptosis. Our data collectively indicate that LK68 suppresses angiogenesis-dependent progression of prevascular micrometastases to macroscopic tumors and their growth, which are clinically accessible and biologically relevant therapeutic targets. We propose that antiangiogenic gene therapy with LK68 is a promising strategy for the treatment of colorectal cancer liver metastasis.Keywords
This publication has 35 references indexed in Scilit:
- Long–Term Expression of Angiostatin Suppresses Metastatic Liver Cancer in MiceHepatology, 2003
- Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis modelBritish Journal of Surgery, 2002
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endotheliumHepatology, 2002
- Angiogenesis of liver metastasesDiseases of the Colon & Rectum, 2000
- Apolipoprotein(a), a Link between Atherosclerosis and Tumor AngiogenesisBiochemical and Biophysical Research Communications, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- The influence of angiogenesis research on management of patients with breast cancerBreast Cancer Research and Treatment, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987